Patents by Inventor Thomas M. Hohn

Thomas M. Hohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7049421
    Abstract: The present invention discloses isolated polynucleotides encoding polypeptides having trichothecene 3-O-acetyltransferase activity, recombinant vectors and host cell comprising said polynucleotides.
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: May 23, 2006
    Assignee: Syngenta Participations AG
    Inventors: Thomas M. Hohn, Cheryl Peters, John Salmeron
  • Patent number: 6696282
    Abstract: The instant invention is drawn towards transformed strains of Fusarium sporotrichioides effective for the production of lycopene. The transformed strains comprise an expression cassette having three genes encoding, respectively, geranylgeranyl-pyrophosphate synthase, phytoene synthase and phytoene desaturase (i.e. Tri5crtE, Tri5crtB and Tri5crtl). The transformed strains of Fusarium sporotrichioides of the instant invention produce lycopene at levels of up to 0.5 milligrams per gram culture dry weight.
    Type: Grant
    Filed: January 14, 2002
    Date of Patent: February 24, 2004
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: James D. Jones, Thomas M. Hohn, Timothy D. Leathers
  • Publication number: 20040034884
    Abstract: The present invention discloses an isolated polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant. In a particular embodiment, trichothecene resistance activity refers to an activity that transfers an acetate to the C-3 position of a trichothecene such as T-2 toxin, HT-2 toxin, isotrichodermol, diacetoxyscirpenol (“DAS”), 3-deacetylcalonectrin, 3,15-dideacetylcalonectrin, scirpentriol, neosolaniol; 15-acetyldeoxynivalenol, nivalenol, 4-acetylnivalenol (fusarenone-X), 4,15-diacetylnivalenol, 4,7,15-acetylnivalenol, and deoxynivalenol (“DON”) and their various acetylated derivatives.
    Type: Application
    Filed: July 7, 2003
    Publication date: February 19, 2004
    Applicant: Syngenta Participations AG
    Inventors: Thomas M. Hohn, Cheryl Peters, John Salmeron
  • Patent number: 6646184
    Abstract: The present invention discloses trichothecene-resistant transgenic plants, plant tissues, plant seeds, and plant cells comprising a heterologous polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to the transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant.
    Type: Grant
    Filed: February 12, 2002
    Date of Patent: November 11, 2003
    Assignee: Syngenta Participations AG
    Inventors: Thomas M. Hohn, Cheryl Peters, John Salmeron
  • Publication number: 20030131376
    Abstract: The invention is directed to nucleic acid sequences derived from Fusarium fungal genes which encode the cell wall-degrading enzymes glucanase, endochitinase, and exochitinase; isolated polypeptides having glucanase, endochitinase or exochitinase activity; recombinant nucleic acid molecules, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides, including expression in plant cells to confer or enhance a plant's resistance to Fusarium and other pathogens.
    Type: Application
    Filed: December 10, 2002
    Publication date: July 10, 2003
    Inventors: Patricia A. Okubara, Ann E. Blechl, Thomas M. Hohn, Randy M. Berka
  • Patent number: 6521435
    Abstract: The invention is directed to nucleic acid sequences derived from Fusarium fungal genes which encode the cell wall-degrading enzymes glucanase, endochitinase, and exochitinase; isolated polypeptides having glucanase, endochitinase or exochitinase activity; recombinant nucleic acid molecules, vectors, and host cells comprising the nucleic acid sequences as well as methods for producing and using the polypeptides, including expression in plant cells to confer or enhance a plant's resistance to Fusarium and other pathogens.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: February 18, 2003
    Assignees: The United States of America as represented by the Secretary of Agriculture, Novozymes Biotech, Inc.
    Inventors: Patricia A. Okubara, Ann E. Blechl, Thomas M. Hohn, Randy M. Berka
  • Publication number: 20030022373
    Abstract: A method which combines the use of polymerase chain reaction (PCR) or oligonucleotide linkers and restriction enzymes which cleave degenerate or variable recognition site sequences to allow the cloning of multiple DNA sequences into a vector is disclosed. In this invention, a plurality of unrelated DNA sequences may be directionally cloned within a single vector by adding onto the ends of the sequences, restriction sites with specific sequences which are cleaved by corresponding restriction endonucleases which recognize degenerate or variable recognition sites and which generate cohesive ends upon cleavage. The compatibility (or ability to anneal) of the cohesive ends on different DNA sequences is controlled by the choice of the nucleotide sequence within the recognition sequences of the restriction endonucleases, allowing the DNA sequences to be inserted or joined in any desired orientation.
    Type: Application
    Filed: January 14, 2002
    Publication date: January 30, 2003
    Inventors: James D. Jones, Thomas M. Hohn, Timothy D. Leathers
  • Publication number: 20020162136
    Abstract: The present invention discloses trichothecene-resistant transgenic plants, plant tissues, plant seeds, and plant cells comprising a heterologous polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to the transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant.
    Type: Application
    Filed: February 12, 2002
    Publication date: October 31, 2002
    Inventors: Thomas M. Hohn, Cheryl Peters, John Salmeron
  • Patent number: 6372479
    Abstract: The instant invention is drawn towards transformed strains of Fusarium sporotrichioides effective for the production of B-carotene. The transformed strains comprise an expression cassette having four genes encoding, respectively, geranylgeranyl-pyrophosphate synthase, phytoene synthase, phytoene desaturase and lycopene cyclase (i.e. Tri5crtE, Tri5crtB, TriScrtI and CrtY). The transformed strains of Fusarium sporotrichioides of the instant invention produce B-carotene at levels of up to 3-4 milligrams per gram of fungus (dry weight).
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: April 16, 2002
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: James D. Jones, Thomas M. Hohn, Timothy D. Leathers
  • Patent number: 6346655
    Abstract: The present invention discloses trichothecene-resistant transgenic plants, plant tissues, plant seeds, and plant cells comprising a heterologous polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to the transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: February 12, 2002
    Assignee: Syngenta Participations AG
    Inventors: Thomas M. Hohn, Cheryl Peters, John Salmeron
  • Patent number: 6184000
    Abstract: A method which combines the use of polymerase chain reaction (PCR) or oligonucleotide linkers and restriction enzymes which cleave degenerate or variable recognition site sequences to allow the cloning of multiple DNA sequences into a vector is disclosed. In this invention, a plurality of unrelated DNA sequences may be directionally cloned within a single vector by adding onto the ends of the sequences, restriction sites with specific sequences which are cleaved by corresponding restriction endonucleases which recognize degenerate or variable recognition sites and which generate cohesive ends upon cleavage. The compatibility (or ability to anneal) of the cohesive ends on different DNA sequences is controlled by the choice of the nucleotide sequence within the recognition sequences of the restriction endonucleases, allowing the DNA sequences to be inserted or joined in any desired orientation.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: February 6, 2001
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: James D. Jones, Thomas M. Hohn, Timothy D. Leathers